Tonix Pharmaceuticals Holding Corp (TNXP) earnings · rev $13.1M
These earnings events as JSON? API free 100/dayTonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
This TNXP earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TNXP revenue for 2025-12-31 was $13.1M. Net income was -$124.0M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. TNXP currently screens at market cap $194.5M.
When the next TNXP 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 29.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TNXP research stays on the stock page; the tape stays on the quote page.
TNXP earnings FAQ
What are TNXP's latest revenue and net income?
Latest cached Tonix Pharmaceuticals Holding Corp (TNXP) revenue for Dec 31, 2025 was $13.1M. Net income was -$124.0M. Statements: https://lician.com/financials/tnxp
What is TNXP's latest diluted EPS?
Latest cached Tonix Pharmaceuticals Holding Corp (TNXP) diluted EPS for Dec 31, 2025 was -$14.57.
What period does the latest TNXP earnings print cover?
The latest cached Tonix Pharmaceuticals Holding Corp (TNXP) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TNXP revenue change from the prior cached period?
Cached Tonix Pharmaceuticals Holding Corp (TNXP) revenue was up 29.8% from $10.1M (Dec 31, 2024) to $13.1M (Dec 31, 2025). Statements: https://lician.com/financials/tnxp
Where are TNXP earnings listed?
Cached earnings facts for Tonix Pharmaceuticals Holding Corp (TNXP) are listed at https://lician.com/earnings/tnxp. Statements: https://lician.com/financials/tnxp
Not investment advice.